CD44+ and CD133+ cells comprised substantial subpopulations (median 5.8–16.1%) of CD117+/cytokeratin+ cells in both tumor and normal samples (Figure 2 A,C), whereas CD90+ cells were less prevalent (median 0.2–2.3%, Figure 2B). Here, KIT is linked to neoplasm.